Lexaria Bioscience (LEXX) Total Debt Growth (3y) (2018 - 2022)
Lexaria Bioscience (LEXX) Total Debt Growth (3y) (2018 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
- |
| Date | Value |
|---|
| May 31, 2022 |
-27.79% |
| Nov 30, 2021 |
-28.80% |
| Aug 31, 2021 |
0.30% |
| May 31, 2021 |
-47.42% |
| Feb 28, 2021 |
233.13% |
| Nov 30, 2020 |
67.72% |
| Aug 31, 2020 |
-10.44% |
| May 31, 2020 |
98.63% |
| Feb 29, 2020 |
-82.18% |
| Nov 30, 2019 |
-53.65% |
| Aug 31, 2019 |
-47.45% |
| May 31, 2019 |
-56.60% |
| Feb 28, 2019 |
-71.32% |
| Nov 30, 2018 |
-41.41% |
| Aug 31, 2018 |
-29.11% |
| Feb 28, 2018 |
46.78% |
